Your browser doesn't support javascript.
loading
Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens.
Puenpatom, Amy; Hull, Michael; McPheeters, Jeffrey; Schwebke, Kay.
Afiliação
  • Puenpatom A; Center for Observational and Real-World Evidence, Merck & Co. Inc., 2000 Galloping Hill Rd, Kenilworth, NJ, 07033, USA.
  • Hull M; Health Economics and Outcomes Research, Optum, 11000 Optum Circle, Eden Prairie, MN, 55344, USA. michael.hull@optum.com.
  • McPheeters J; Health Economics and Outcomes Research, Optum, 11000 Optum Circle, Eden Prairie, MN, 55344, USA.
  • Schwebke K; Health Economics and Outcomes Research, Optum, 11000 Optum Circle, Eden Prairie, MN, 55344, USA.
Clin Drug Investig ; 37(7): 687-697, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28386819

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C / Insuficiência Renal Crônica / Falência Renal Crônica Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C / Insuficiência Renal Crônica / Falência Renal Crônica Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article